AngioDynamics (ANGO), a leading provider of medical devices for vascular access, surgery, peripheral vascular disease and oncology, has seen a dramatic turnaround in its business this year. The company anticipates that its earnings will progressively improve each quarter because of higher revenue and stronger margins of its new products. I feel that ANGO's share price will see a gradual up move from the current level. In this investment thesis I will focus on the opportunities that lie ahead of ANGO.
AngioDynamics manufactures and sells a wide range of medical, surgical and diagnostic devices used by professional healthcare providers. The devices are generally used in minimally invasive, image-guided procedures. Most of the products of ANGO are intended to...
Only subscribers can access this article, which is part of the PRO research library covering 3,559 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: